Biograph Vision vs VX1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Siemens Healthineers
VS
by Volta Medical

AI Verdict

While both tools leverage AI in cardiology, their applications are distinct. Biograph Vision is a hardware-based PET/CT imaging system for diagnostics across multiple specialties, including cardiology, focusing on image quality and scan efficiency. VX1, on the other hand, is an AI software specifically designed to assist cardiac electrophysiologists in real-time during ablation procedures for atrial fibrillation and tachycardia.

Choose Biograph Vision if…

Choose the Biograph Vision if your institution requires a high-resolution, high-sensitivity PET/CT imaging system for comprehensive diagnostics across oncology, cardiology, and neurology. It is ideal for facilities aiming to reduce scan times and patient radiation dose while achieving precise detection of small lesions and detailed imaging for treatment planning and monitoring.

View Biograph Vision →

Choose VX1 if…

Choose Volta Medical's VX1 if your cardiology department specializes in atrial fibrillation and atrial tachycardia ablation procedures and seeks to enhance real-time guidance for electrophysiologists. This AI software is best suited for standardizing outcomes and reducing inter-operator variability by assisting in the precise identification of dispersed electrograms during complex ablation procedures.

View VX1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Biograph Vision VX1
Pricing Contact vendor Contact for pricing
Deployment On-premise (physical medical device) Software integrated with existing electrophysiology (EP) lab mapping and recording systems.
FDA Status Yes AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Biograph Vision aims to enhance patient and user experience by reducing scan times and patient dose, and features a large bore for patient comfort. VX1 is described as intuitive and user-friendly, designed to integrate with existing EP lab systems and reduce inter-operator variability. Both tools emphasize ease of use and improved patient experience within their respective domains, making a definitive winner difficult without direct comparative user feedback.

Clinical Value

Biograph Vision

Biograph Vision offers high resolution, sensitivity, and ultra-fast time-of-flight for precise diagnostics in oncology, cardiology, and neurology, aiming to reduce scan times and patient dose, and has demonstrated improved image quality in studies. VX1 assists cardiac electrophysiologists in real-time identification of dispersed electrograms during ablation procedures, with studies showing it can standardize outcomes and achieve high rates of AF termination. While both offer significant clinical value, Biograph Vision's broader application across multiple specialties and demonstrated improvements in fundamental diagnostic imaging metrics give it a slight edge in overall clinical impact.

Pricing & Value

Tie

Both Biograph Vision and VX1 list their pricing as 'contact vendor' or 'contact for pricing,' indicating a lack of public transparency. Without specific pricing details or publicly available cost-benefit analyses for either product, it is impossible to determine which offers better value. Therefore, this dimension is a tie.

Enterprise Readiness

Biograph Vision

Biograph Vision is a Siemens Healthineers product, a large and established medical technology company, suggesting robust enterprise-level support, deployment, and integration capabilities for a physical medical device. VX1, while FDA-cleared and compatible with most EP lab systems, is from Volta Medical, a smaller, newer company. The inherent nature of a large-scale hardware system like Biograph Vision, backed by a global enterprise, generally implies a higher degree of enterprise readiness in terms of infrastructure, maintenance, and long-term support compared to a software solution from a smaller company.

Innovation

Biograph Vision

Biograph Vision features Optiso Ultra Dynamic Range detector technology with 3.2-mm LSO crystals and SiPMs, achieving high volumetric resolution and ultra-fast time-of-flight performance, representing significant hardware innovation in PET/CT imaging. VX1 utilizes AI-guided real-time identification of dispersed electrograms, which is innovative for standardizing ablation procedures. While both are innovative, Biograph Vision's advancements in fundamental imaging hardware technology, pushing the boundaries of physical detection and resolution, appear to be a more foundational innovation compared to VX1's software-based analytical innovation.

Support & Docs

Biograph Vision

Siemens Healthineers, as a large, established company, is likely to have extensive support infrastructure and comprehensive documentation for a complex medical device like Biograph Vision, including operator and service manuals. While VX1 has a user manual and clinical evidence publications, the breadth and depth of support and documentation from a smaller company like Volta Medical are generally less extensive than those from a global leader in medical imaging hardware.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Biograph Vision VX1
Name Biograph Vision VX1
Company Siemens Healthineers Volta Medical
Description Biograph Vision is a Siemens Healthineers PET/CT imaging system offering high resolution, sensitivity, and ultra-fast time-of-flight performance for precise diagnostics in oncology, cardiology, and neurology, aiming to reduce scan times and patient dose. Volta Medical's VX1 is an FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Categories Cardiology AI, Oncology AI, Radiology & Imaging AI Cardiology AI, Surgical AI
Specialties Nuclear Medicine, Oncology, Radiology Cardiology

Videos

Demos, reviews, and walkthroughs featuring Biograph Vision and VX1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Biograph Vision, as a PET/CT imaging system, integrates into radiology and nuclear medicine workflows, providing images and data that are then managed within the hospital's existing PACS and EHR systems. Siemens Healthineers offers AIDAN, an intelligent imaging platform with features like FlowMotion AI and PET FAST Workflow AI, designed to optimize clinical operations and accelerate patient workflow by automating tasks like image transfer and data export to PACS. VX1 is an AI software that integrates with existing electrophysiology (EP) lab mapping and recording systems, assisting cardiologists in real-time during ablation procedures. It is compatible with most EP recording, 3D navigation systems, and mapping catheters, aiming to reduce inter-operator variability and standardize outcomes.
Biograph Vision offers high spatial resolution with 3.2-mm LSO crystals and ultra-fast time-of-flight (TOF) performance (214-249 ps), leading to improved image quality, better detectability of small lesions, and more accurate quantification in oncology, cardiology, and neurology. This can reduce scan times and patient dose while enhancing diagnostic precision. VX1's accuracy lies in its AI-guided real-time identification of dispersed electrograms during AFib and atrial tachycardia ablation procedures, which has been shown to standardize the detection of abnormal electrograms across different operators and centers. The clinical significance of utilizing VX1 to identify these areas for catheter ablation has been evaluated in studies, with results demonstrating high freedom from atrial fibrillation after follow-up.
For Biograph Vision, the learning curve is associated with operating a sophisticated PET/CT system, though its AI-enabled features like FlowMotion AI and PET FAST Workflow AI are designed to optimize workflows and simplify tasks, potentially easing the operational burden. Siemens Healthineers provides support for their hardware and software, with a focus on optimizing clinical operations and patient experience. VX1 is described as intuitive and user-friendly, with its AI algorithms trained on a large database of expert-annotated electrograms, which may contribute to a fast learning curve and standardized outcomes across operators. Volta Medical aims to drastically improve cardiac arrhythmia management and offers support for their AI software solution.
Biograph Vision aims to deliver time-to-value by significantly reducing scan times (as low as 3 minutes for whole-body scans) and lowering injected radiopharmaceutical doses, which can boost productivity and increase patient throughput. Its high sensitivity and faster TOF performance contribute to quicker, high-quality image acquisition. VX1 contributes to time-to-value by assisting cardiac electrophysiologists in real-time identification of dispersed electrograms during ablation procedures, potentially leading to more efficient and standardized procedures and reducing inter-operator variability. This can lead to improved outcomes and potentially fewer repeat procedures, enhancing overall efficiency in the EP lab.
For Biograph Vision, the first system was installed at the Hospital of the University of Pennsylvania in February 2019, and other institutions like RPA have installed multiple units and reported increased patient throughput and improved image quality. There are also published performance evaluations and studies from institutions like the University of Pennsylvania and the University of Groningen. For VX1, Volta Medical has published peer-reviewed results from their Ev-AIFib-Proof-of-Concept-Study, demonstrating that VX1 allowed for robust center-to-center standardization of electrogram-based ablation outcomes. They have also initiated the TAILORED-AF trial, a randomized controlled clinical trial to further evaluate VX1-guided ablation.
For Biograph Vision, as a physical imaging system, multi-site rollout would involve significant logistical planning for installation, calibration, and staff training at each location. However, its AI-enabled features aim to standardize protocols and personalize exams, which could aid in consistent image acquisition across different sites. The system is designed to fit into rooms housing previous Biograph mCT family scanners, potentially simplifying some infrastructure considerations. For VX1, its design to reduce inter-operator variability and standardize outcomes, as demonstrated in multi-center studies like Ev-AIFib, suggests it is well-suited for multi-site rollouts to promote a consistent approach to identifying dispersed electrograms during ablation procedures. Its compatibility with most existing EP lab equipment also facilitates easier integration across different sites.
AI Tool Finder
AI-powered search. Results may not be comprehensive.